On this page, you will find Nasseo, Inc.'s official press releases.
SAN DIEGO, Calif., Oct. 3, 2016 /PRNewswire/ -- Nasseo, Inc., a medical technology company dedicated to developing enhanced surface technologies for dental and orthopedic applications, has been awarded a Small Business Innovation Research Grant from the National Science Foundation (NSF).
The NSF grant funding will further Nasseo's work improving spinal implants by using a nano¬engineered surface coating; Nasseo will conduct feasibility studies with an optimized nanotube surface on medical grade polyether ether ketone (PEEK). When applied to PEEK implants, Nasseo's nanotube surface technology maintains the benefit of the material's radiolucency while providing an enhanced bone response. The Company's aim is to improve the osseointegration of PEEK spinal interbody fusion devices.
"The National Science Foundation's interest in advancing our work is a distinct honor. The grant will accelerate development of our unique platform surface technology, with an ultimate goal of improving clinical outcomes for orthopedic patient care," says Nasseo's Co¬founder and CTO Dr. Garrett Cale Smith, who will also serve as primary investigator on the study. Prior to Nasseo, Smith co¬founded Oculeve, Inc., a medical technology company acquired by Allergan PLC.
Nasseo holds four issued patents on nanotube platform technology.
To date, over 10 years of research have validated Nasseo's nanotube surface technology; numerous studies have demonstrated enhanced bone cell response and anti¬bacterial properties compared with conventional implant surfaces.
About Nasseo, Inc.
Nasseo, Inc. is a privately owned medical device company developing enhanced surface technologies for dental, spinal, and orthopedic applications. Nasseo was founded based on the intellectual property developed at the University of California, San Diego. The Company's TiArray Dental Implant System has received 510(k) clearance. Nasseo is headquartered in San Diego, CA, with research & development facilities in Phoenix, AZ.
CONTACT: Dr. Garrett Cale Smith, Nasseo, Inc., 1-866-207-8919, firstname.lastname@example.org
Peoria, AZ & San Diego, CA - September 16, 2013 - Nasseo, Inc. announced today that the U.S. Food and Drug Administration ("FDA") has cleared its TiArray™ Dental Implant system for commercial sale in the U.S. It is the first commercial application of Nasseo's proprietary surface modification technology, which was initially developed over 8 years out of UC San Diego Bioengineering and Materials Science Departments, and the Bio-Implant Laboratory at Lund University in Sweden. The inflammation ("peri-implantitis") that many patients suffer in reaction to existing dental implants is currently a significant cause of both bone loss and dental implant failure over time. Patients and doctors alike are seeking better performing implants which lower inflammation and promote faster healing.
The TiArray™ Dental Implant system was developed to address a gap in medical care that is currently adding significant costs to the US healthcare system: the failure of dental implants. The $1B+ US dental implant market is growing quickly as clinicians move away from dentures and bridges. However, existing dental implants often fail, requiring repeated clinical visits and additional implants, which is expensive for patients and an inefficient use of clinician time. Due to high dental implant failure rates and growing peri-implantitis concerns, certain high-risk patient populations (e.g. heavy smokers) are being advised against implants altogether. Nasseo aims to address these concerns and provide a longer lasting dental implant.
Dr. Garrett Cale Smith, Co-Founder and CEO, says "Achieving the significant milestone of FDA clearance allows us to continue to increase the value of our technology by running clinical trials with key opinion leaders at leading centers. The FDA clearance of the Nasseo TiArray™ Dental Implant system is an important step toward our goal of providing dentists and millions of patients worldwide with improved treatment options."
While the company's FDA clearance news will accelerate its timeline for clinical trials and commercialization, Nasseo is excited to attend two prominent investor and partnership conferences later this month. Dr. Smith will present the company's work at the Rocky Mountain Life Sciences Investor & Partnership Conference taking place September 18-19 at The Ritz-Carlton in Denver, while Kayvon Pourmirzaie, Co-Founder and COO, will represent Nasseo at the NCET2 Global 1000 Corporate Venturing Conference on September 17-18 at the Marriott San Mateo. Nasseo is seeking Series A investment and corporate partnerships.
Pourmirzaie says, "Our success so far has been based not only upon our novel technology, but also the enthusiastic support of the scientific and business communities. We will continue to evaluate new strategic partnerships that support our efforts to conduct clinically relevant studies and bring Nasseo’s highly differentiated TiArray™ Dental Implant system to market."
For more information about Nasseo's surface modification technology, the TiArray™ Dental Implant system, investment opportunities, or to request meetings at the events listed above, please contact Kayvon Pourmirzaie at kayvon(at)nasseo(dot)com.
About the Dental Implant Market
In the United States, over 70% of adults have lost at least one permanent tooth, while 25% of American adults over 65 have lost all of their teeth. This demand amounts to a fast growing $1B+ US market. However, existing implants on the market experience high failure rates and peri-implantitis issues depending upon the tooth's location and other factors and are not recommended for a number of large populations including diabetics, heavy smokers, and patients with gum disease. The demand for dental implants is expected to double over the next five years.
Peoria, AZ - June 18, 2013 - Nasseo, Inc. today announces that it has been named the 2013 Innovation Challenge Winner out of hundreds of applicants by the Arizona Commerce Authority (ACA) in its spring Arizona Innovation Challenge. The Arizona Innovation Challenge (AIC) awards the most money in the country for a technology commercialization challenge, granting a financial award to what it deems to be the world's most promising technology ventures. Nasseo's state of the art dental and orthopedic implant surface modification technology captured the attention of the ACA this year. With this victory, Nasseo is honored to accept a $250,000 grant award to commercialize their first product, the TiArray™ Dental Implant.
In the ACA's press release about the award, Nasseo was described as "Inventive Arizona entrepreneurs who are creating technology solutions with potential global implications." Nasseo is headquartered at the BioInspire Medtech incubator in Peoria, AZ which is sponsored by BioAccel who also invested $300K into the company as part of the seed round.
Nasseo's medical innovation has resonated with audiences across industries. The company most recently won CONNECT's Life Sciences Capital Competition earlier this year, earning it prestigious membership as a CONNECT Portfolio Company and the distinction as a "Rock Star of Innovation" by CONNECT. Prior to that, Nasseo had been invited to showcase its work at the 2012 World's Best Technology (WBT) Innovation Marketplace and the 2013 National Innovation Showcase. And in its earliest victory, Nasseo made history at the UC San Diego (UCSD) Business Plan Competition, as the first startup to win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year.
Garrett Cale Smith, PhD, CEO of Nasseo says, "We appreciate AIC's recognition of the urgency to commercialize our ground-breaking technology. Not only is this implant technology unique, but the implications are far-reaching. This award will offer a significant boost as we initiate production and sales of the Nasseo TiArray™ Dental Implant for patients in need."
The company's efforts to raise a Series A investment round are also underway. Along with today's award, the Series A funding will be used toward further developing Nasseo's TiArray™ Dental Implant towards successful commercialization to improve dental implant standards. The funding will also be used to develop a PEEK based spinal implant that integrates Nasseo's same core implant surface modification technology.
Peoria, AZ & San Diego, CA - March 12, 2013 - Nasseo, Inc. is honored to announce that it has won CONNECT's Life Sciences Capital Competition and has subsequently earned the distinction of becoming a CONNECT Portfolio Company. Competing against a large pool of highly qualified California-based life science companies, Nasseo was selected by a panel of distinguished judges for its "radical innovation in the Southern California start-up scene". Pursuant to its victory, the Company has been invited to present its proprietary implant surface modification technology for dental and orthopedic applications to a group of venture capital investors at the March 14th Capital Roadshow in Palo Alto, California at the offices of Morrison & Foerster.
Nasseo's first product, the TiArray™ Dental Implant is an easy-to-use, cost-effective dental implant system for patients with poor circulatory issues (e.g. diabetics, smokers) as well as for the general population. Nasseo's technology addresses the ongoing problem of dental implant failures, which account for $1.2B annually in patient healthcare costs in the United States.
Nasseo's selection earlier this year to CONNECT Springboard, a distinguished business mentorship and networking program, was a key milestone for the company. The CONNECT Springboard program introduced Nasseo to serial life sciences entrepreneur Bill Gerhart for executive mentorship. Mr. Gerhart was previously Founder, President & CEO of Elevation Pharmaceuticals, which developed new aerosol therapies for underserved respiratory patient populations, and which he sold in 2012 to Sunovion Pharmaceuticals for up to $430 million. After undergoing a rigorous screening and completing the mentoring process with Mr. Gerhart, Nasseo was further vetted to present in the CONNECT Life Sciences Capital Competition.
Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, "Bill Gerhart has successfully led several life sciences companies through the growth stages that Nasseo is now experiencing. His insight on how to strategically position the company for investment was instrumental. We are grateful for his continued support."
Nasseo's TiArray™ Dental Implant system and its proprietary technology have drawn significant interest from the scientific and investment communities. Last year, the company presented at World's Best Technology (WBT) Innovation Marketplace 2012, and also received the 1st place prize at the 6th Annual UC San Diego Entrepreneur Challenge Business Plan Competition, where it was the first startup to ever win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year. Nasseo most recently announced that it had been selected into the BioAccel/BioInspire™ medical technology incubator, and had subsequently closed its $520K seed round of funding.
Dr. Garrett Cale Smith, PhD, CEO of Nasseo, says, "CONNECT has offered us a number of dynamic opportunities to grow our company. We look forward to the opportunity to introduce the Nasseo TiArray™ Dental Implant system to a new audience of VCs at the March 14th Capital Roadshow."
Additionally, CONNECT has invited Nasseo to be one of eight emerging companies across all disciplines to present at its annual Rock Stars of Innovation Summit in San Diego on April 12, a premier showcase at the Hard Rock Hotel to be attended by over 250 technology and investment leaders. The company is moving forward with plans to raise a Series A investment round in 2014 to catalyze production and sales.
Peoria, AZ & San Diego, CA - February 15, 2013 - Nasseo, Inc., a medical device company based in San Diego, CA, is pleased to announce that it has closed its $520K seed financing round. BioInspire™, a medical technology incubator that funded Nasseo earlier this year, leads the round along with an internationally renowned dentist. The Nasseo TiArray™ Dental Implant system, the first product based on Nasseo's proprietary implant surface modification technology, has been developed for diabetics and smokers with poor bone healing who are seeking dental implants but have limited treatment options with today's technology. Nasseo offers dentists cost-effective, high quality, and easy-to-use implants that significantly improve clinician productivity and expand patient care options.
BioInspire™ is a collaborative partnership between BioAccel, Plaza Companies, and the City of Peoria, Arizona, that provides working capital and space to those companies selected and admitted per its application criteria. BioInspire™ focuses on directly addressing the challenges of commercializing medical devices by providing portfolio companies with assistance in funding, partnerships and mentorship.
Dr. Garrett Cale Smith, Co-Founder and CEO of Nasseo, says, "We are honored to be selected as a BioInspire™ portfolio company and to be identified as a medtech company that is poised for investment based upon the unmet clinical need that our enabling technology is addressing."
Nasseo's technology has received increasingly enthusiastic reception from members across diverse sectors of the scientific and investment community. Most recently, Nasseo participated in World's Best Technology (WBT) Innovation Marketplace 2012, the premier showcase for life science and technology innovation. There, Nasseo was selected as part of an elite group to present its surface modification technology to venture capitalists and other attendees at the event, which is sponsored by Northrup Grumman. Kayvon Pourmirzaie, JD, Nasseo's Co-Founder and COO, confirms, "Our inclusion in BioInspire™ is a significant milestone as it gives us access to a wealth of resources and opportunities that will support moving forward aggressively with our go-to-market strategy."
Nasseo is joining the BioInspire™ community at the same time as it experiences internal growth with the addition of Mr. Brian Jaffe to its Board of Advisors. Mr. Jaffe has over 15 years of senior level experience in dental implants and medical devices and is currently the president of Quantive LLC, a consulting firm specializing in helping dental and medical device companies launch new products in the United States. He was previously Vice President of Sales and Marketing at Implant Direct, a leading global manufacturer of dental implants and prosthetics that was acquired by Danaher Corporation for $300M in 2010. He holds an MBA from Harvard Business School and a Masters in Science Degree in Mechanical Engineering from UC Berkeley.
Dr. Smith says, "We are joining BioInspire™ and bringing Brian in at an exciting time in Nasseo’s growth. We will continue to seek out every opportunity, internally and externally, to successfully commercialize our first product, the TiArray™ Dental Implant system, to reach a large and underserved group of patients."
San Diego, CA - August 22, 2012 - Nasseo, Inc. is a medical device company that has been selected to present its dental and orthopedic technology at the World's Best Technology (WBT) Innovation Marketplace 2012, presented by Northrup Grumman. Nasseo is among an elite 130 companies and technology innovators from across the globe that have been chosen by the WBT Selection Committee to present their technology at WBT 2012, the premier showcase for innovators in the fields of life science, nanotech, material science and information technologies.
"We are pleased to include Nasseo, Inc. in this choice group of emerging companies and technologies to our exclusive forum of institutional investors, angel investors, and corporate licensees," said Paul Huleatt, CEO of the WBT Innovation Marketplace.
Nasseo's first product, the Nasseo TiArray™ Dental Implant system, integrates its proprietary surface modification technology to improve osseointegration. Many dental patients are currently advised not to obtain implants due to high failure rates. These patients include individuals with poor circulatory health issues, such as diabetes and smokers, and individuals who have taken bisphosphonates for an extended period of time. Nasseo's dental implant system targets this large and growing patient demographic.
Dr. Garrett Cale Smith, PhD, Nasseo's Co-Founder and CEO, co-invented the technology in an effort to provide better solutions for patients and clinicians. Dr. Smith says, "When implants fail, dentists lose time, money, and patient confidence. The dental industry continues to modify implant surfaces utilizing grit-blasting and coating techniques which do not take into account the porous structure of bone at the molecular level. Nasseo's novel surface modification technology aims to provide smarter and stronger bone-to-implant bonding to create better treatment options for both patients and dentists."
Today's WBT Innovation Marketplace announcement is the latest recognition for the medical device company. Nasseo recently received top prize in both the UCSD Entrepreneur Challenge Executive Summary and Business Plan 2012 Competitions, the first company to accomplish this in the same year. The company, which has already closed on its seed financing round led by a leading dental clinician, looks forward to the WBT Showcase. Nasseo will present its technology at this deal-focused event to seasoned venture investors and Fortune 500 licensing scouts representing a variety of growth oriented industries.
Dr. Smith says, "To have our work recognized in this way by one of the most prestigious events in the technology industry is a great source of motivation for us. Ultimately, we feel the WBT Innovation Marketplace is recognizing not only Nasseo's unique technology, but the current market and patient need for stronger-bonded and longer-lasting dental implants."
The WBT Innovation Marketplace will showcase select companies on October 24-26, 2012 in San Diego at the Convention Center.
San Diego, CA - June 6, 2012 - Nasseo, Inc. received the 1st place prize of $57,000 in cash and legal services at the 6th Annual UC San Diego Entrepreneur Challenge Business Plan Competition, making it the first startup to win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year.
The competition, which boasted a record number of applications in 2012, is UC San Diego's premier entrepreneurial event and aims to recognize inspiring startups. The event has been a turning point for a number of successful startup companies, namely; NeuroVigil, Biological Dynamics, Cognionics, Cypher Genomics, Lumedyne Technologies and The Nicholas Conor Cancer Institute, each of which won either the Business Plan or Executive Summary Entrepreneur Challenge competitions.
Nasseo's initial product, the Nasseo TiArray™ Dental Implant system, arose out of a need to address the failure rate of dental implants. Implant failures are not only inconvenient and time-consuming, but can be uncomfortable and expensive for patients to endure. Additionally, a number of individuals with poor circulatory and bone growth issues, are currently discouraged from receiving implants because a high rate of failures. Nasseo TiArray™ addresses bone-to-implant bonding at the molecular level by integrating the company's proprietary surface modification technology.
By creating a dental implant system, Nasseo hopes to create new treatment options for previously unreached patient populations.
Dr. Garrett Cale Smith (Co-Founder, CEO) says, "Nasseo's TiArray™ Dental Implant system is focused on two things: bringing smarter implant technology to market and reaching an untapped patient demographic in need of technological advancements. We are thrilled to be recognized by these esteemed judges in the business community, and it reaffirms our strategy to bring our technology to the patients who need it most."
San Diego, CA - April 18, 2012 - Nasseo, Inc. is proud to announce that it has received the 1st place prize of $7,500 in cash and legal services at the UC San Diego Entrepreneur Challenge's Executive Summary competition with what the school calls "groundbreaking ideas that may radically improve healthcare delivery."
At the competition, Nasseo presented the Executive Summary for its novel dental implant system and noted that although dental implants are "one of the fastest growing, multi-billion dollar markets within the US healthcare industry…current implants have a failure rate of over 10%." Nasseo's product aims to directly address this failure rate, to provide benefits to patients and clinicians. Using proprietary surface modification technology, Nasseo's dental implant system addresses bone-to-implant bonding issues at the molecular level to create what it calls a "smarter implant."
The UC San Diego Entrepreneur Challenge allows cross-disciplinary teams in a number of industries to compete for the prize. An esteemed panel of professionals from across science, technology, and business industries judged the contest and awards were announced before a crowd of hundreds of students, professors, and business professionals in La Jolla, CA.
Nasseo's cross-disciplinary team includes Dr. Garrett Cale Smith (Co-Founder, CEO), who holds a Ph.D. in bioengineering from UCSD and is a Stanford Biodesign Fellow Alumni, and Kayvon Pourmirzaie (Co-Founder, COO) who holds a J.D. (Cum Laude) from the University of San Diego School of Law and a B.S. in bioengineering from UCSD. The team also includes Gary Johnston, a Ph.D. candidate in bioengineering at UCSD, Sean Madanipour, an MBA candidate at the Rady School of Management, and Handan Yildiran, a visiting bioengineering student.
Kayvon Pourmirzaie says, "This competition is about finding emerging startups that have developed ground-breaking technologies, so we are excited to receive this recognition. Nasseo's science is well-documented, and we look forward to developing our proprietary dental implant system."